LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/UnitedHealth Beats Feds in Medicare Fraud Case
Legal & Regulatory and Reimbursement

UnitedHealth Beats Feds in Medicare Fraud Case

October 10, 2017 2 min read Premium comments

Advertisement

UnitedHealth Beats Feds in Medicare Fraud Case
Source: PublicDomainPictures.net
Secondary

A federal judge in California has given UnitedHealth Group Inc. a big victory against the U.S. Department of Justice (DOJ) over allegations that the company cooked the diagnosis books of patients to boost Medicare Advantage (MA) profits.

“Shotgun Pleading”

According to Law360, on October 5, 2017, U.S. District Judge John F. Walter wrote that the government False Claim Act (FCA) suit is too vague, doesn’t show intentional wrongdoing, and doesn’t show that the government would have withheld payment if it had been aware of the alleged violations.

The judge said the lawsuit was a “classic shotgun pleading that wholly fails to precisely allege how UnitedHealth entities committed wrongdoing.”

DOJ Precedent

This was the first time that the government joined a whistleblower suit filed by James Swoben alleging Medicare Advantage fraud. The issue centered around MA’s “risk adjustment” payments, which go up if insurer cover sicker patients.

The government accused the insurer of not properly overseeing shoddy chart reviews by a company called Healthcare Partners LLC, thereby billing the government for unsubstantiated diagnoses.

The government alleged that UnitedHealth had audited a large provider group called HealthCare Partners and found records indicating overlooked diagnoses that would legitimately increase its Medicare Advantage payments, as well as dicey diagnoses that would decrease the payments. According to the DOJ, the company looked into the overlooked diagnoses but not the suspicious ones.

Advertisement

In 2010, DOJ reached a roughly $23 million settlement in an FCA suit alleging Medicare Advantage fraud by Florida-based Medical Resources LLC, but that wasn’t a whistleblower case.

Law360 reported that government auditors have estimated that billions of dollars in excess risk adjustment money is being paid out every year.

UnitedHealth is the largest player in the Medicare Advantage market. The alleged misconduct in the Swoben case dated back about 10 years.

When the government joined the whistleblower suit, company officials said they were confident the company complied with Medicare Advantage program rules and were transparent with regulators about how it interpreted the government’s “murky policies.”

Looks like the Judge also thought the lawsuit was murky.

More to Come

But this fight is not going away quickly. The government is still after the insurer in a separate suit with similar allegations in a California federal court. UnitedHealth is punching back with a counterattack in a D.C. federal court that accuses the federal government of unfairly holding it to a higher anti-fraud standard than traditional Medicare.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy